inhaled milrinone
Showing 1 - 25 of 2,123
Mitral Valve Replacement, Pulmonary Hypertension, Inhaled Milrinone Trial in Shibin Al Kawm (Inhaled Milrinone, IV Milrinone)
Active, not recruiting
- Mitral Valve Replacement
- +3 more
- Inhaled Milrinone
- IV Milrinone
-
Shibīn Al Kawm, Menoufia, EgyptMenoufia University Hospitals
Apr 19, 2023
Right Heart Failure, Right Ventricular Dysfunction Trial (Combined Epoprostenol Sodium & Milrinone, Normal saline)
Not yet recruiting
- Right Heart Failure
- Right Ventricular Dysfunction
- Combined Epoprostenol Sodium & Milrinone
- Normal saline
- (no location specified)
Jul 5, 2022
Pulmonary Hypertension Due to Left Heart Disease Trial in Zagazig (Milrinone inhalation, Milrinone infusion)
Recruiting
- Pulmonary Hypertension Due to Left Heart Disease
- Milrinone inhalation
- Milrinone infusion
-
Zagazig, Sharkia, EgyptZagazig University
Dec 25, 2021
Heart Failure, Cardiomyopathy Trial in Kansas City, Nashville (Inhaled nebulized milrinone)
Recruiting
- Heart Failure
- Cardiomyopathy
- Inhaled nebulized milrinone
-
Kansas City, Kansas
- +1 more
Mar 9, 2021
Hypertension, Pulmonary, Cardiac Failure, Pulmonary Vascular Resistance Abnormality Trial in Athens (levosimendan at a dose of 6
Recruiting
- Hypertension, Pulmonary
- +2 more
- levosimendan at a dose of 6 mcg/kg
- milrinone at a dose of 50 mcg/kg
-
Athens, GreeceOnassis Cardiac Surgery Center
Feb 8, 2022
Acute Respiratory Distress Syndrome, Ventilation Perfusion Mismatch Trial (Nitric Oxide)
Not yet recruiting
- Acute Respiratory Distress Syndrome
- Ventilation Perfusion Mismatch
- Nitric Oxide
- (no location specified)
Apr 12, 2023
Cardiac Surgery
Recruiting
- Right Ventricular Dysfunction
- +2 more
-
Montreal, Quebec, CanadaMontreal Heart Institute
Aug 31, 2022
Hypertension, Pulmonary, Cardiac Failure, Pulmonary Vascular Resistance Abnormality Trial in Athens (levosimendan at a dose of 3
Recruiting
- Hypertension, Pulmonary
- +2 more
- levosimendan at a dose of 3 mcg/kg
- +2 more
-
Athens, GreeceOnassis Cardiac Surgery Center
Feb 8, 2022
Milrinone on Right Ventricular Strain in Cardiac Surgery
Not yet recruiting
- Ischemic Heart Disease
- Valvular Heart Disease
- (no location specified)
Oct 10, 2023
Paceport Swan-Ganz Data Collection Study
Recruiting
- Right Ventricular Dysfunction
- +2 more
-
Montreal, Quebec, CanadaMontreal Heart Institute
Aug 30, 2021
Dobutamine, Milrinone , Pediatrics , Low Cardiac Output Trial in Giza (Dobutamine)
Not yet recruiting
- Dobutamine, Milrinone , Pediatrics , Low Cardiac Output
-
Giza, EgyptCairo University Children'S Hospital
Aug 17, 2023
Acute Kidney Disease, Chronic Kidney Disease, Cardiac Surgery Trial in Tomsk (Sham treatment, 80-ppm NO)
Recruiting
- Acute Kidney Disease
- +3 more
- Sham treatment
- 80-ppm NO
-
Tomsk, Russian FederationCardiology Research Institute, Tomsk National Research Medical C
Mar 13, 2023
Cerebral Vasospasm, Subarachnoid Hemorrhage Trial in Nantes (Rhythmic tolerance, Hematological tolerance, Milrinone efficiency
Completed
- Cerebral Vasospasm
- Subarachnoid Hemorrhage
- Rhythmic tolerance
- +3 more
-
Nantes, FranceCHU Nantes
Mar 2, 2022
Vasospasm Trial in France (Milrinone 1 Mg/mL Solution for Injection, Saline solution for injection)
Recruiting
- Vasospasm
- Milrinone 1 Mg/mL Solution for Injection
- Saline solution for injection
-
Angers, France
- +5 more
Nov 2, 2022
Oral Nimodipine, Milrinone, Vascular Spasm After Traumatic Subarachnoidhaemorrhage Trial in Zagazig (nimodipine, Oral Nimodipine
Completed
- Oral Nimodipine
- +2 more
- nimodipine
- Oral Nimodipine and milrinone
-
Zagazig, El Sharkia, Egypt
- +1 more
May 24, 2022
Bronchiolitis Obliterans Syndrome Due to and After Lung Transplantation (Disorder), Chronic Lung Allograft Dysfunction Trial in
Recruiting
- Bronchiolitis Obliterans Syndrome Due to and After Lung Transplantation (Disorder)
- Chronic Lung Allograft Dysfunction
- Sirolimus
- Placebo
-
San Francisco, CaliforniaUniversity of California, San Francisco
Aug 28, 2023
Asthma Trial in Spain (To compare in both treatment arms the percentage of patients controlled at week 52.)
Recruiting
- Asthma
- To compare in both treatment arms the percentage of patients controlled at week 52.
-
Inca, Baleares, Spain
- +16 more
Jun 16, 2023
Aneurysmal Subarachnoid Hemorrhage Trial in Bordeaux, Toulouse (Milrinone Injection, Placebo)
Recruiting
- Aneurysmal Subarachnoid Hemorrhage
- Milrinone Injection
- Placebo
-
Bordeaux, France
- +1 more
Mar 30, 2022
Persistent Pulmonary Hypertension of the Newborn, Hypoxemic Respiratory Failure Trial in Sacramento (95% - 99% SpO2 target)
Enrolling by invitation
- Persistent Pulmonary Hypertension of the Newborn
- Hypoxemic Respiratory Failure
- 95% - 99% SpO2 target
-
Sacramento, CaliforniaUniversity of California-Davis
Jan 25, 2022
Anaphylactic Reaction Trial in Adelaide (Epinephrine, Placebo)
Not yet recruiting
- Anaphylactic Reaction
- Epinephrine
- Placebo
-
Adelaide, South Australia, AustraliaCMAX Clinical Research
Aug 22, 2023
Autoimmune Pulmonary Alveolar Proteinosis Trial in Worldwide (Molgramostim, Placebo, PARI eFlow nebulizer system)
Completed
- Autoimmune Pulmonary Alveolar Proteinosis
- Molgramostim
- +2 more
-
Los Angeles, California
- +29 more
Dec 14, 2022
COPD (COPD) Trial in Manchester, Nottingham, Southampton (Interferon Beta-1A, Placebo)
Completed
- Chronic Obstructive Pulmonary Disease (COPD)
- Interferon Beta-1A
- Placebo
-
Belfast, United Kingdom
- +15 more
Jan 3, 2023
COPD Exacerbation, COPD Exacerbation Trial (Furosemide, Normal saline)
Not yet recruiting
- Chronic Obstructive Pulmonary Disease Exacerbation
- COPD Exacerbation
- Furosemide
- Normal saline
- (no location specified)
Mar 3, 2023